Nanobiotix Joins Euronext Tech Leaders
Analysis based on 8 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026
The inclusion of Nanobiotix in the Euronext Paris Tech Leaders Index is expected to increase its visibility among international investors, potentially leading to increased trading volume and investor interest in Nanobiotix stock. This could positively impact the biotechnology sector by highlighting innovative European companies.
Nanobiotix, a late-clinical stage biotechnology company, announced its inclusion in the Euronext Paris Tech Leaders segment and Euronext Paris Tech Leaders Index on June 2, 2026. This initiative, launched by Euronext Paris in 2022, aims to increase the visibility and attractiveness of Europe's leading and high-growth technology companies among international investors. Laurent Levy, CEO of Nanobiotix, stated that this inclusion recognizes the company's progress and the potential of physics-based innovation in healthcare. Nanobiotix, headquartered in Paris, France, and with subsidiaries in Cambridge, Massachusetts, United States, is listed on Euronext Paris Paris and Nasdaq-100.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard